Capella Bioscience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Capella Bioscience Ltd
- Target Recruit Count
- 56
- Registration Number
- NCT05323110
- Locations
- 🇬🇧
HMR, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath